Revision history of "US Food and Drug Administration FDA has issued Boxed Warning due to increased risk of death from gout medicine Uloric febuxostat"

Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 12:46, 19 September 2019Binderup44boesen (talk | contribs). . (1,316 bytes) (+1,316). . (Created page with "conduct a large postmarket safety clinical trial. The trial was performed in more than 6,000 patients with gout treated with either Uloric or allopurinol. The main result was...")